Incyte Corp.

Incyte Corp.

Sector: Pharmaceutical Preparations Region: DE, United States

: | Nasdaq: INCY

Similar to: Skystar Bio-Pharmaceutical Co., Bohai Pharmaceuticals Group, Inc., Ipsen SA

Incyte Corp. is a biopharmaceutical company. It focuses on the discovery, development and commercialization of proprietary small molecule drugs to treat serious unmet medical needs. The company's product, Jakafi (ruxolitinib), a JAK1 and JAK2 inhibitor, is currently approved in the U.S. for the treatment of intermediate or high-risk myelofibrosis and is in development as a potential treatment for other cancers. Incyte was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.

News & Analysis

You may also be interested in: